 Shares of Global Blood Therapeutics Inc. GBT, 48.47 jumped 9.5 in trading on Friday after The Wall Street Journal reported that Pfizer Inc. PFE, -0.49 is considering buying the company for about 5 billion. There were media reports earlier this week that Global Blood Therapeutics, which markets a sickle-cell treatment, is attracting takeover interest. 